Ginkgo Bioworks Holdings (DNA) said Tuesday that it will receive a research milestone payment of $9 million from Merck (MRK) after completing the first milestone in their partnership.
They will now advance to the next phase, which will focus on continuing to improve the production process, Ginkgo Bioworks said.
Price: 8.68, Change: -0.08, Percent Change: -0.91
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments